Basecamp Bio

About:

Basecamp Bio develops cell and gene therapies, regenerative medicine, and immunotherapies.

Website: https://www.elevate.bio/basecamp

Top Investors: Qiming Venture Partners

Description:

Basecamp Bio is a cell and gene therapy research and development company that develops cell and gene therapies, regenerative medicine, and immunotherapies.

Total Funding Amount:

$14M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Waltham, Massachusetts, United States

Founded Date:

2021-01-01

Founders:

David Hallal, Mitchell Finer, Vikas Sinha

Number of Employees:

11-50

Last Funding Date:

2021-03-23

IPO Status:

Private

Industries: